相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Comparative Review of Chemotherapy-Induced Peripheral Neuropathy in In Vivo and In Vitro Models
Sandy Eldridge et al.
TOXICOLOGIC PATHOLOGY (2020)
High mobility group box-1-toll-like receptor 4-phosphatidylinositol 3-kinase/protein kinase B-mediated generation of matrix metalloproteinase-9 in the dorsal root ganglion promotes chemotherapy-induced peripheral neuropathy
Haibo Gu et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Microbiota: a novel regulator of pain
Manon Defaye et al.
JOURNAL OF NEURAL TRANSMISSION (2020)
Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors
Alberto Potenzieri et al.
PAIN (2020)
Lorcaserin: A review of its preclinical and clinical pharmacology and therapeutic potential
Guy A. Higgins et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Phase III randomized, placebo-controlled, double-blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin-induced peripheral neurotoxicity in stage II/III colorectal cancer
De-shen Wang et al.
CANCER MEDICINE (2020)
Multicenter randomized controlled trial to evaluate the efficacy and tolerability of frozen gloves for the prevention of chemotherapy-induced peripheral neuropathy
A. J. M. Beijers et al.
ANNALS OF ONCOLOGY (2020)
Unexpected Ca2+-mobilization of oxaliplatin via H1 histamine receptors
A. Potenzieri et al.
CELL CALCIUM (2020)
Prevention of chemotherapy-induced peripheral neuropathy: A review of recent findings
Eiman Y. Ibrahim et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
Mesenchymal stem cells in chemotherapy-induced peripheral neuropathy: A new challenging approach that requires further investigations
Khaled F. Al-Massri et al.
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2020)
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity
Paola Alberti et al.
NEUROPHARMACOLOGY (2020)
Systematic review of cognitive sequelae of non-central nervous system cancer and cancer therapy
Noemi Cerulla Torrente et al.
JOURNAL OF CANCER SURVIVORSHIP (2020)
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity
Cristina Meregalli et al.
ARCHIVES OF TOXICOLOGY (2020)
Effect of Repetitive Transcranial Magnetic Stimulation on Pain Management: A Systematic Narrative Review
Seoyon Yang et al.
FRONTIERS IN NEUROLOGY (2020)
Formononetin ameliorates oxaliplatin-induced peripheral neuropathy via the KEAP1-NRF2-GSTP1 axis
Yuan Fang et al.
REDOX BIOLOGY (2020)
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
Charles L. Loprinzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Vincristine-induced peripheral neuropathy: A mini-review
Gui-zhou Li et al.
NEUROTOXICOLOGY (2020)
Targeting Axon Integrity to Prevent Chemotherapy-Induced Peripheral Neuropathy
Virendra Bhagawan Chine et al.
MOLECULAR NEUROBIOLOGY (2019)
Interventional and preventive effects of aripiprazole and ceftriaxone used alone or in combination on oxaliplatin-induced tactile and cold allodynia in mice
Kinga Salat et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
A review of complementary therapies with medicinal plants for chemotherapy-induced peripheral neuropathy
Bei-Yu Wu et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2019)
Pharmacological Manipulation of Trk, p75NTR, and NGF Balance Restores Memory Deficit in Global Ischemia/Reperfusion Model in Rats
Ali Mohamed Choucry et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2019)
The National Cancer Institute Clinical Trials Planning Meeting for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy
Susan G. Dorsey et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Anti-allodynic and anti-inflammatory effects of 17α-hydroxyprogesterone caproate in oxaliplatin-induced peripheral neuropathy
Constanza A. Miguel et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2019)
L-Carnosine protects against Oxaliplatin-induced peripheral neuropathy in colorectal cancer patients: A perspective on targeting Nrf-2 and NF-κB pathways
Rana Yehia et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2019)
Recent Developments of Novel Pharmacologic Therapeutics for Prevention of Chemotherapy-Induced Peripheral Neuropathy
Shuiying Hu et al.
CLINICAL CANCER RESEARCH (2019)
Targeting strategies for chemotherapy-induced peripheral neuropathy: does gut microbiota play a role?
Shanshan Zhong et al.
CRITICAL REVIEWS IN MICROBIOLOGY (2019)
Simple surface EMG recording as a noninvasive screening method for the detection of acute oxaliplatin-induced neurotoxicity: a feasibility pilot study
Sandra A. S. van den Heuvel et al.
NEUROSCIENCE LETTERS (2019)
Engagement of MicroRNA-155 in Exaggerated Oxidative Stress Signal and TRPA1 in the Dorsal Horn of the Spinal Cord and Neuropathic Pain During Chemotherapeutic Oxaliplatin
Fenghua Miao et al.
NEUROTOXICITY RESEARCH (2019)
Chemotherapy-induced peripheral neuropathy: where are we now?
Lesley A. Colvin
PAIN (2019)
Duloxetine, a Balanced Serotonin-Norepinephrine Reuptake Inhibitor, Improves Painful Chemotherapy-Induced Peripheral Neuropathy by Inhibiting Activation of p38 MAPK and NF-κB
Jing Meng et al.
FRONTIERS IN PHARMACOLOGY (2019)
Search of anti-allodynic compounds from Plantaginis Semen, a crude drug ingredient of Kampo formula Goshajinkigan
Kazufumi Toume et al.
JOURNAL OF NATURAL MEDICINES (2019)
HCN3 ion channels: roles in sensory neuronal excitability and pain
Sergio Lainez et al.
JOURNAL OF PHYSIOLOGY-LONDON (2019)
Clinician-rated measures for distal symmetrical axonal polyneuropathy ACTTION systematic review
Jennifer S. Gewandter et al.
NEUROLOGY (2019)
Effectiveness assessment of riluzole in the prevention of oxaliplatin-induced peripheral neuropathy: RILUZOX-01: protocol of a randomised, parallel, controlled, double-blind and multicentre study by the UNICANCER-AFSOS Supportive Care intergroup
Nicolas Kerckhove et al.
BMJ OPEN (2019)
Changes in the glutamate biomarker expression in rats vulnerable or resistant to the rewarding effects of cocaine and their reversal by ceftriaxone
Ewa Niedzielska-Andres et al.
BEHAVIOURAL BRAIN RESEARCH (2019)
Pharmacological Treatment of Chemotherapy-Induced Neuropathic Pain: PPARγ Agonists as a Promising Tool
Nara Lins Meira Quintao et al.
FRONTIERS IN NEUROSCIENCE (2019)
Role of non-macrophage cell-derived HMGB1 in oxaliplatin-induced peripheral neuropathy and its prevention by the thrombin/thrombomodulin system in rodents: negative impact of anticoagulants
Maho Tsubota et al.
JOURNAL OF NEUROINFLAMMATION (2019)
Upregulation of ERK phosphorylation in rat dorsal root ganglion neurons contributes to oxaliplatin-induced chronic neuropathic pain
Toyoaki Maruta et al.
PLOS ONE (2019)
DF2726A, a new IL-8 signalling inhibitor, is able to counteract chemotherapy-induced neuropathic pain
Laura Brandolini et al.
SCIENTIFIC REPORTS (2019)
New pharmacological effect of fulvestrant to prevent oxaliplatin-induced neurodegeneration and mechanical allodynia in rats
Shota Yamamoto et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Molecular Concept of Diabetic wound Healing: Effective Role of Herbal Remedies
Amro Mohamed Soliman et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2019)
Concomitant Medications and Risk of Chemotherapy-Induced Peripheral Neuropathy
Lara Sanchez-Barroso et al.
ONCOLOGIST (2019)
Preventive action of benztropine on platinum-induced peripheral neuropathies and tumor growth
Olivier Cerles et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Depletion of Mitofusin-2 Causes Mitochondrial Damage in Cisplatin-Induced Neuropathy
Ilja Bobylev et al.
MOLECULAR NEUROBIOLOGY (2018)
Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial
Jordi Bruna et al.
NEUROTHERAPEUTICS (2018)
Evaluation of cebranopadol, a dually acting nociceptin/orphanin FQ and opioid receptor agonist in mouse models of acute, tonic, and chemotherapy-induced neuropathic pain
Kinga Salat et al.
INFLAMMOPHARMACOLOGY (2018)
Time-shifted co-administration of sub-analgesic doses of ambroxol and pregabalin attenuates oxaliplatin-induced cold allodynia in mice
Anna Furgala et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
The preventive effect of sensorimotor- and vibration exercises on the onset of Oxaliplatin- or vinca-alkaloid induced peripheral neuropathies - STOP
Fiona Streckmann et al.
BMC CANCER (2018)
Possible association of CAG repeat polymorphism in KCNN3 encoding the potassium channel SK3 with oxaliplatin-induced neurotoxicity
Benjamin Anon et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
Nrf2 inhibits oxaliplatin-induced peripheral neuropathy via protection of mitochondrial function
Yang Yang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity
Alix F. Leblanc et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Incidence and disease burden of chemotherapy-induced peripheral neuropathy in a population-based cohort
Arya Shah et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
Ganglioside GM1 protects against high altitude cerebral edema in rats by suppressing the oxidative stress and inflammatory response via the PI3K/AKT-Nrf2 pathway
Gu Gong et al.
MOLECULAR IMMUNOLOGY (2018)
Oxaliplatin Modulates the Characteristics of Voltage-Gated Calcium Channels and Action Potentials in Small Dorsal Root Ganglion Neurons of Rats
Linda-Isabell Schmitt et al.
MOLECULAR NEUROBIOLOGY (2018)
Participation of pro-inflammatory cytokines in neuropathic pain evoked by chemotherapeutic oxaliplatin via central GABAergic pathway
Dongsheng Xu et al.
MOLECULAR PAIN (2018)
Sigma-1 receptor: a new player in neuroprotection against chemotherapy-induced peripheral neuropathy
Jordi Bruna et al.
NEURAL REGENERATION RESEARCH (2018)
Oxaliplatin-induced changes in expression of transient receptor potential channels in the dorsal root ganglion as a neuropathic mechanism for cold hypersensitivity
Akiko Chukyo et al.
NEUROPEPTIDES (2018)
Selective HCN1 block as a strategy to control oxaliplatin-induced neuropathy
F. Resta et al.
NEUROPHARMACOLOGY (2018)
Chemokine CCL2 and its receptor CCR2 in the dorsal root ganglion contribute to oxaliplatin-induced mechanical hypersensitivity
Amina M. Illias et al.
PAIN (2018)
Oxaliplatin-induced changes in microbiota, TLR4+cells and enhanced HMGB1 expression in the murine colon
Vanesa Stojanovska et al.
PLOS ONE (2018)
Comparative study of the effects of venlafaxine and duloxetine on chemotherapy-induced peripheral neuropathy
Negin Farshchian et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
Novel amide derivatives of 1,3-dimethyl-2,6-dioxopurin-7-yl-alkylcarboxylic acids as multifunctional TRPA1 antagonists and PDE4/7 inhibitors: A new approach for the treatment of pain
Grazyna Chlon-Rzepa et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Targeting the TREK-1 potassium channel via riluzole to eliminate the neuropathic and depressive-like effects of oxaliplatin
Laura Poupon et al.
NEUROPHARMACOLOGY (2018)
Protective effects of mangafodipir against chemotherapy-induced ovarian damage in mice
Ying Qin et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2018)
Natural Product Interventions for Chemotherapy and Radiotherapy-Induced Side Effects
Qing-Yu Zhang et al.
FRONTIERS IN PHARMACOLOGY (2018)
Pain in Platin-Induced Neuropathies: A Systematic Review and Meta-Analysis
Vasiliki Brozou et al.
PAIN AND THERAPY (2018)
Persistent prevention of oxaliplatin-induced peripheral neuropathy using calmangafodipir (PledOx((R))): a placebo-controlled randomised phase II study (PLIANT)
Bengt Glimelius et al.
ACTA ONCOLOGICA (2018)
Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601
E. M. L. Smith et al.
EUROPEAN JOURNAL OF CANCER CARE (2017)
Niclosamide Inhibits Oxaliplatin Neurotoxicity while Improving Colorectal Cancer Therapeutic Response
Olivier Cerles et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Potential role of selected antiepileptics used in neuropathic pain as human GABA transporter isoform 1 (GAT1) inhibitors-Molecular docking and pharmacodynamic studies
Lukasz Fijalkowski et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Lifestyle-Related Factors in the Self-Management of Chemotherapy-Induced Peripheral Neuropathy in Colorectal Cancer: A Systematic Review
Tess M. E. Derksen et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2017)
Oxaliplatin-Induced Peripheral Neuropathy and Identification of Unique Severity Groups in Colorectal Cancer
Kathleen A. Griffith et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2017)
Chemotherapy-Induced Neuropathy in Cancer Survivors
Christine Miaskowski et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2017)
Gut microbiota is critical for the induction of chemotherapy-induced pain
Shiqian Shen et al.
NATURE NEUROSCIENCE (2017)
Antinociceptive, antiallodynic and antihyperalgesic effects of the 5-HT1A, receptor selective agonist, NLX-112 in mouse models of pain
Kinga Salat et al.
NEUROPHARMACOLOGY (2017)
Pregabalin for the Prevention of Oxaliplatin-Induced Painful Neuropathy: A Randomized, Double-Blind Trial
Daniel Ciampi De Andrade et al.
ONCOLOGIST (2017)
FTY720 inhibits the Nrf2/ARE pathway in human glioblastoma cell lines and sensitizes glioblastoma cells to temozolomide
Li Zhang et al.
PHARMACOLOGICAL REPORTS (2017)
A pilot study of minocycline for the prevention of paclitaxel-associated neuropathy: ACCRU study RU221408I
Deirdre R. Pachman et al.
SUPPORTIVE CARE IN CANCER (2017)
Mangafodipir a Selective Cytoprotectant - with Special Reference to Oxaliplatin and Its Association to Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Jan Olof G. Karlsson et al.
TRANSLATIONAL ONCOLOGY (2017)
Intravenous Lidocaine: Old-School Drug, New Purpose-Reduction of Intractable Pain in Patients with Chemotherapy Induced Peripheral Neuropathy
Sandra A. S. van den Heuvel et al.
PAIN RESEARCH & MANAGEMENT (2017)
Taxanes and platinum derivatives impair Schwann cells via distinct mechanisms
Satoshi Imai et al.
SCIENTIFIC REPORTS (2017)
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
Hana Starobova et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
Herbal Medicine AC591 Prevents Oxaliplatin-Induced Peripheral Neuropathy in Animal Model and Cancer Patients
Xiaolan Cheng et al.
FRONTIERS IN PHARMACOLOGY (2017)
Distinct Mechanism of Cysteine Oxidation-Dependent Activation and Cold Sensitization of Human Transient Receptor Potential Ankyrin 1 Channel by High and Low Oxaliplatin
Takahito Miyake et al.
FRONTIERS IN PHYSIOLOGY (2017)
Characterisation of Immune and Neuroinflammatory Changes Associated with Chemotherapy-Induced Peripheral Neuropathy
Preet G. S. Makker et al.
PLOS ONE (2017)
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights
Paola Marmiroli et al.
PLOS ONE (2017)
Excessive spinal glutamate transmission is involved in oxaliplatin-induced mechanical allodynia: a possibility for riluzole as a prophylactic drug
Shota Yamamoto et al.
SCIENTIFIC REPORTS (2017)
Biomarker analysis using circulating tumor DNA in patients treated with sorafenib for advanced hepatocellular carcinoma
S. R. Park et al.
ANNALS OF ONCOLOGY (2017)
The molecular genetics of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
J. Cliff et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Clinical and genetic predictors of paclitaxel neurotoxicity based on patient- versus clinician-reported incidence and severity of neurotoxicity in the ICON7 trial
S. B. Park et al.
ANNALS OF ONCOLOGY (2017)
Clinical and preclinical perspectives on Chemotherapy-Induced Peripheral Neuropathy (CIPN): a narrative review
S. J. L. Flatters et al.
BRITISH JOURNAL OF ANAESTHESIA (2017)
Platinum-induced neurotoxicity: A review of possible mechanisms
Ozkan Kanat et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2017)
Roles of Transient Receptor Potential Ankyrin 1 in Oxaliplatin-Induced Peripheral Neuropathy
Takayuki Nakagawa et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2017)
miR-15b mediates oxaliplatin-induced chronic neuropathic pain through BACE1 down regulation
Naomi Ito et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy
Maria Sereno et al.
BMC CANCER (2017)
MC11C4: a pilot randomized, placebo-controlled, double-blind study of venlafaxine to prevent oxaliplatin-induced neuropathy
Collin Zimmerman et al.
SUPPORTIVE CARE IN CANCER (2016)
Celecoxib reverts oxaliplatin-induced neuropathic pain through inhibiting PI3K/Akt2 pathway in the mouse dorsal root ganglion
Shu-Ping Jiang et al.
EXPERIMENTAL NEUROLOGY (2016)
Preventing oxaliplatin-induced neurotoxicity: rationale and design of phase Ib randomized, double-blind, placebo-controlled, cross-over trials for early clinical evaluation of investigational therapeutics
Catherine H. Han et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2016)
Oxaliplatin administration increases expression of the voltage-dependent calcium channel α2δ-1 subunit in the rat spinal cord
Ken Yamamoto et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2016)
Chemotherapy-induced pain and neuropathy: a prospective study in patients treated with adjuvant oxaliplatin or docetaxel
Lise Ventzel et al.
PAIN (2016)
Ensuring transparency and minimization of methodologic bias in preclinical pain research: PPRECISE considerations
Nick A. Andrews et al.
PAIN (2016)
Cold sensitivity of TRPA1 is unveiled by the prolyl hydroxylation blockade-induced sensitization to ROS
Takahito Miyake et al.
NATURE COMMUNICATIONS (2016)
Identification and Characterization of New Chemical Entities Targeting Apurinic/Apyrimidinic Endonuclease 1 for the Prevention of Chemotherapy-Induced Peripheral Neuropathys
Mark R. Kelley et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Associations of genetic polymorphisms of the transporters organic cation transporter 2 (OCT2), multidrug and toxin extrusion 1 (MATE1), and ATP-binding cassette subfamily C member 2 (ABCC2) with platinum-based chemotherapy response and toxicity in non-small cell lung cancer patients
Chen-Yue Qian et al.
CHINESE JOURNAL OF CANCER (2016)
Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives
Marianne Ewertz et al.
ACTA ONCOLOGICA (2015)
Peripheral neuropathy in colorectal cancer survivors: The influence of oxaliplatin administration. Results from the population-based PROFILES registry
Antoinetta J. M. Beijers et al.
ACTA ONCOLOGICA (2015)
Spinal neuroimmune activation is independent of T-cell infiltration and attenuated by A3 adenosine receptor agonists in a model of oxaliplatin-induced peripheral neuropathy
Kali Janes et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Antinociceptive activity of the new triple reuptake inhibitor NS18283 in a mouse model of chemotherapy-induced neuropathic pain
G. Hache et al.
EUROPEAN JOURNAL OF PAIN (2015)
Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives
Laura Poupon et al.
EXPERT OPINION ON DRUG SAFETY (2015)
Well-balanced commensal microbiota contributes to anti-cancer response in a lung cancer mouse model
Q.-F. Gui et al.
GENETICS AND MOLECULAR RESEARCH (2015)
Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance)
Deirdre R. Pachman et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Candidate pathway-based genetic association study of platinum and platinum-taxane related toxicity in a cohort of primary lung cancer patients
Cassandra Johnson et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2015)
Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms?
V. A. Carozzi et al.
NEUROSCIENCE LETTERS (2015)
Platinum-Induced Neurotoxicity and Preventive Strategies: Past, Present, and Future
Abolfazl Avan et al.
ONCOLOGIST (2015)
Neuropathic pain phenotyping by international consensus (NeuroPPIC) for genetic studies: a NeuPSIG systematic review, Delphi survey, and expert panel recommendations
Oliver van Hecke et al.
PAIN (2015)
Assessment of chemotherapy-induced peripheral neuropathy using the LDIFLARE technique: a novel technique to detect neural small fiber dysfunction
Sanjeev Sharma et al.
BRAIN AND BEHAVIOR (2015)
Corneal Confocal Microscopy Detects Small Fibre Neuropathy in Patients with Upper Gastrointestinal Cancer and Nerve Regeneration in Chemotherapy Induced Peripheral Neuropathy
Maryam Ferdousi et al.
PLOS ONE (2015)
Prevention and treatment of chemotherapy-induced peripheral neuropathy
Jennifer Piccolo et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2014)
Characterization of Acute and Chronic Neuropathies Induced by Oxaliplatin in Mice and Differential Effects of a Novel Mitochondria-targeted Antioxidant on the Neuropathies
Satoshi Toyama et al.
ANESTHESIOLOGY (2014)
A Quantitative Sensory Analysis of Peripheral Neuropathy in Colorectal Cancer and Its Exacerbation by Oxaliplatin Chemotherapy
Mariana de Carvalho Barbosa et al.
CANCER RESEARCH (2014)
Glial role in oxaliplatin-induced neuropathic pain
Lorenzo Di Cesare Mannelli et al.
EXPERIMENTAL NEUROLOGY (2014)
The Development and Maintenance of Paclitaxel-induced Neuropathic Pain Require Activation of the Sphingosine 1-Phosphate Receptor Subtype 1
Kali Janes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Treatment of oxaliplatin-induced peripheral neuropathy by intravenous mangafodipir
Romain Coriat et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
Dawn L. Hershman et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium and Magnesium to Prevent Oxaliplatin-Induced Sensory Neurotoxicity (N08CB/Alliance)
Charles L. Loprinzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Minocycline, a microglial inhibitor, blocks spinal CCL2-induced heat hyperalgesia and augmentation of glutamatergic transmission in substantia gelatinosa neurons
Chung-Yu Huang et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Intrathecal miR-96 Inhibits Nav1.3 Expression and Alleviates Neuropathic Pain in Rat Following Chronic Construction Injury
Hong-Ping Chen et al.
NEUROCHEMICAL RESEARCH (2014)
Involvement of α7 nAChR subtype in rat oxaliplatin-induced neuropathy: Effects of selective activation
Lorenzo Di Cesare Mannelli et al.
NEUROPHARMACOLOGY (2014)
ASTROCYTES, BUT NOT MICROGLIA, ARE ACTIVATED IN OXALIPLATIN AND BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY IN THE RAT
C. R. Robinson et al.
NEUROSCIENCE (2014)
Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
Marta Seretny et al.
PAIN (2014)
GLT-1 transporter: An effective pharmacological target for various neurological disorders
Neha Soni et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2014)
A systematic review on chronic oxaliplatin-induced peripheral neuropathy and the relation with oxaliplatin administration
A. J. M. Beijers et al.
SUPPORTIVE CARE IN CANCER (2014)
TRPA1 channels mediate acute neurogenic inflammation and pain produced by bacterial endotoxins
Victor Meseguer et al.
NATURE COMMUNICATIONS (2014)
Artificial Intelligence in Medicine and Cardiac Imaging: Harnessing Big Data and Advanced Computing to Provide Personalized Medical Diagnosis and Treatment
Steven E. Dilsizian et al.
CURRENT CARDIOLOGY REPORTS (2014)
Antiallodynia and antihyperalgesia effects of ceftriaxone in treatment of chronic neuropathic pain in rats
Valiollah Hajhashemi et al.
ACTA NEUROPSYCHIATRICA (2013)
Phase I drug-interaction study of effects of calcium and magnesium infusions on oxaliplatin pharmacokinetics and acute neurotoxicity in colorectal cancer patients
Catherine H. Han et al.
BMC CANCER (2013)
Voltage-Gated Sodium Channel Polymorphisms Play a Pivotal Role in the Development of Oxaliplatin-Induced Peripheral Neurotoxicity Results From a Prospective Multicenter Study
Andreas A. Argyriou et al.
CANCER (2013)
Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancer
Kyung-Hun Lee et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Novel Therapeutic Strategy to Prevent Chemotherapy-Induced Persistent Sensory Neuropathy By TRPA1 Blockade
Gabriela Trevisan et al.
CANCER RESEARCH (2013)
Enhanced antitumor activity of cerulenin combined with oxaliplatin in human colon cancer cells
Risa Shiragami et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy A Randomized Clinical Trial
Ellen M. Lavoie Smith et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
The complexity of adverse side-effects to biological agents
Francois Aubin et al.
JOURNAL OF CROHNS & COLITIS (2013)
Morphologic Features and Glial Activation in Rat Oxaliplatin-Dependent Neuropathic Pain
Lorenzo Di Cesare Mannelli et al.
JOURNAL OF PAIN (2013)
Bacteria activate sensory neurons that modulate pain and inflammation
Isaac M. Chiu et al.
NATURE (2013)
An animal model of oxaliplatin-induced cold allodynia reveals a crucial role for Nav1.6 in peripheral pain pathways
Jennifer R. Deuis et al.
PAIN (2013)
Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2
Jason A. Sprowl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
A TRPA1 antagonist reverts oxaliplatin-induced neuropathic pain
Cristina Nativi et al.
SCIENTIFIC REPORTS (2013)
Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial
J. P. Durand et al.
ANNALS OF ONCOLOGY (2012)
Mitotoxicity and bortezomib-induced chronic painful peripheral neuropathy
H. Zheng et al.
EXPERIMENTAL NEUROLOGY (2012)
OPINION Sex differences in pain and pain inhibition: multiple explanations of a controversial phenomenon
Jeffrey S. Mogil
NATURE REVIEWS NEUROSCIENCE (2012)
TRPA1 and TRPV4 mediate paclitaxel-induced peripheral neuropathy in mice via a glutathione-sensitive mechanism
Serena Materazzi et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2012)
Anticancer drug oxaliplatin induces acute cooling-aggravated neuropathy via sodium channel subtype NaV1.6-resurgent and persistent current
Ruth Sittl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA
Sherry L. Wolf et al.
SUPPORTIVE CARE IN CANCER (2012)
Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors
Juliette Descoeur et al.
EMBO MOLECULAR MEDICINE (2011)
The effect of prophylactic calcium and magnesium infusions on the incidence of neurotoxicity and clinical outcome of oxaliplatin-based systemic treatment in advanced colorectal cancer patients
N. Knijn et al.
EUROPEAN JOURNAL OF CANCER (2011)
Protection against oxaliplatin-induced mechanical hyperalgesia and intraepidermal nerve fiber loss by minocycline
J. Boyette-Davis et al.
EXPERIMENTAL NEUROLOGY (2011)
Functional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathy
Huaien Zheng et al.
EXPERIMENTAL NEUROLOGY (2011)
Intravenous Calcium and Magnesium for Oxaliplatin-Induced Sensory Neurotoxicity in Adjuvant Colon Cancer: NCCTG N04C7
Axel Grothey et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Cisplatin induced Mitochondrial DNA damage in dorsal root ganglion neurons
Jewel L. Podratz et al.
NEUROBIOLOGY OF DISEASE (2011)
Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation
Romina Nassini et al.
PAIN (2011)
Allopregnanolone prevents and suppresses oxaliplatin-evoked painful neuropathy: Multi-parametric assessment and direct evidence
Laurence Meyer et al.
PAIN (2011)
NeuPSIG guidelines on neuropathic pain assessment
Maija Haanpaa et al.
PAIN (2011)
Mexiletine Reverses Oxaliplatin-Induced Neuropathic Pain in Rats
Nobuaki Egashira et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2010)
Sensitization of capsaicin and icilin responses in oxaliplatin treated adult rat DRG neurons
Uma Anand et al.
MOLECULAR PAIN (2010)
NGF protects Dorsal Root Ganglion neurons from oxaliplatin by modulating JNK/Sapk and ERK1/2
Arianna Scuteri et al.
NEUROSCIENCE LETTERS (2010)
Enhancement of axonal potassium conductance reduces nerve hyperexcitability in an in vitro model of oxaliplatin-induced acute neuropathy
Ruth Sittl et al.
NEUROTOXICOLOGY (2010)
Oxaliplatin-induced acute thrombocytopenia
Jessica M Mason et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2010)
Mechanical Allodynia Induced by Paclitaxel, Oxaliplatin and Vincristine: Different Effectiveness of Gabapentin and Different Expression of Voltage-Dependent Calcium Channel α2δ-1 Subunit
Punarn Gauchan et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2009)
Antinociceptive synergistic effect of spinal mGluR2/3 antagonist and glial cells inhibitor on peripheral inflammation-induced mechanical hypersensitivity
Ting Zhang et al.
BRAIN RESEARCH BULLETIN (2009)
Neuronal expression of copper transporter 1 in rat dorsal root ganglia: association with platinum neurotoxicity
Johnson J. Liu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Involvement of increased expression of transient receptor potential melastatin 8 in oxaliplatin-induced cold allodynia in mice
Punam Gauchan et al.
NEUROSCIENCE LETTERS (2009)
Supraspinal role of protein kinase C in oxaliplatin-induced neuropathy in rat
M. Norcini et al.
PAIN (2009)
Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: A prospective quantified sensory assessment study
N. Attal et al.
PAIN (2009)
Lidocaine-induced Brugada syndrome phenotype linked to a novel double mutation in the cardiac sodium channel
Hector M. Barajas-Martinez et al.
CIRCULATION RESEARCH (2008)
Vascularization of the dorsal root ganglia and peripheral nerve of the mouse: Implications for chemical-induced peripheral sensory neuropathies
Juan M. Jimenez-Andrade et al.
MOLECULAR PAIN (2008)
Effect of cytokines on neuronal excitability
Maria Schaefers et al.
NEUROSCIENCE LETTERS (2008)
The effects of oxaliplatin, an anticancer drug, on potassium channels of the peripheral myelinated nerve fibres of the adult rat
Alexia Kagiava et al.
NEUROTOXICOLOGY (2008)
Predictive factors of oxaliplatin neurotoxicity: The involvement of the oxalate outcome pathway
Laurence Gamelin et al.
CLINICAL CANCER RESEARCH (2007)
Behavioral and pharmacological description of oxaliplatin-induced painful neuropathy in rat
Bing Ling et al.
PAIN (2007)
Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum-DNA binding
Lauren E. Ta et al.
NEUROTOXICOLOGY (2006)
Dysregulation of cellular calcium homeostasis in chemotherapy-evoked painful peripheral neuropathy
C Siau et al.
ANESTHESIA AND ANALGESIA (2006)
Oxaliplatin-induced neurotoxicity and the development of neuropathy
AV Krishnan et al.
MUSCLE & NERVE (2005)
Oxaliplatin-induced neurotoxicity: Acute hyperexcitability and chronic neuropathy
RJ Lehky et al.
MUSCLE & NERVE (2004)
Oxaliplatin reintroduction in patients previously treated with leucovorin, fluorouracil and oxaliplatin for metastatic colorectal cancer
F Maindrault-Goebel et al.
ANNALS OF ONCOLOGY (2004)
Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy
V Raghavendra et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment
A Trotti et al.
SEMINARS IN RADIATION ONCOLOGY (2003)
Effects of temperature on neuromuscular electrophysiology
SB Rutkove
MUSCLE & NERVE (2001)
A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels
F Grolleau et al.
JOURNAL OF NEUROPHYSIOLOGY (2001)
Subcutaneous administration of amifostine: A promising therapeutic option in patients with oxaliplatin-related peripheral sensitive neuropathy
M Penz et al.
ANNALS OF ONCOLOGY (2001)
Iodo-resiniferatoxin, a new potent vanilloid receptor antagonist
P Wahl et al.
MOLECULAR PHARMACOLOGY (2001)
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
A de Gramont et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
